文献速递复苏、休克与脓毒症儿科与产科急症

法国校园内院外心脏骤停:基于RéAC登记处的全国性回顾性队列研究

Out-of-hospital cardiac arrests occurring at school in France: A nation-wide retrospective cohort study from the RéAC registry.
PubMed 文献 · Resuscitation · 2023-06-26
一句话结论法国校园内院外心脏骤停虽罕见(86/25,071例公共场所事件),但目击率高、旁观者心肺复苏和自动体外除颤器使用更多,30天生存率34.9%优于其他公共场所的11.6%。

本研究基于法国全国性RéAC院外心脏骤停登记处(2011年7月至2023年3月),比较校园内与其他公共场所发生的院外心脏骤停的特征与结局。在149,088例全国院外心脏骤停中,公共场所事件25,071例,其中校园内86例(0.3%)、其他公共场所24,985例(99.7%)。校园内事件患者更年轻(中位42.5岁 vs 58岁,p<0.001)、更多为医疗原因(90.7% vs 63.8%,p<0.001)、更多被旁观者目击(93.0% vs 73.4%,p<0.001)并接受旁观者心肺复苏(78.8% vs 60.6%,p=0.001),无血流时间更短(中位2分钟 vs 7分钟),旁观者自动体外除颤器应用率(38.9% vs 18.4%)和除颤率(23.6% vs 7.9%)更高(均p<0.001)。校园内患者自主循环恢复率(47.7% vs 31.8%,p=0.002)、入院时生存率(60.5% vs 30.7%,p<0.001)、30天生存率(34.9% vs 11.6%,p<0.001)及30天神经功能良好生存率(25.9% vs 9.2%,p<0.001)均更高。作者认为校园内院外心脏骤停虽罕见但预后特征和结局良好,自动体外除颤器的使用虽较其他场所更常见,但仍应改进。

要点

  • 校园内院外心脏骤停仅占公共场所事件的0.3%(86/25,071),但旁观者目击率93.0%、旁观者心肺复苏率78.8%,均高于其他公共场所(73.4%、60.6%)。
  • 校园内事件无血流时间中位2分钟,短于其他公共场所的7分钟;旁观者自动体外除颤器应用率38.9% vs 18.4%,除颤率23.6% vs 7.9%(均p<0.001)。
  • 校园内患者30天生存率34.9%,其他公共场所11.6%(p<0.001);30天神经功能良好生存率25.9% vs 9.2%(p<0.001)。
  • 校园内患者自主循环恢复率47.7% vs 31.8%(p=0.002),入院时生存率60.5% vs 30.7%(p<0.001)。
  • 作者认为校园内自动体外除颤器的使用虽较其他场所更常见,但仍应改进。

适用人群与场景

  • 法国全国范围内2011年7月至2023年3月发生的院外心脏骤停,比较校园内与其他公共场所事件。

研究设计与关键结果

  • 研究类型:全国性、多中心、回顾性队列研究,基于法国全国人群基础的RéAC院外心脏骤停登记处(2011年7月至2023年3月)。
  • 样本量:全国院外心脏骤停149,088例,其中公共场所事件25,071例;校园内86例(0.3%),其他公共场所24,985例(99.7%)。
  • 校园内 vs 其他公共场所:中位年龄42.5岁 vs 58岁(p<0.001);医疗原因90.7% vs 63.8%(p<0.001);旁观者目击93.0% vs 73.4%(p<0.001);旁观者心肺复苏78.8% vs 60.6%(p=0.001);无血流时间中位2分钟 vs 7分钟。
  • 校园内 vs 其他公共场所:旁观者自动体外除颤器应用38.9% vs 18.4%,除颤23.6% vs 7.9%(均p<0.001)。
  • 校园内 vs 其他公共场所:自主循环恢复47.7% vs 31.8%(p=0.002);入院时生存60.5% vs 30.7%(p<0.001);30天生存34.9% vs 11.6%(p<0.001);30天神经功能良好生存25.9% vs 9.2%(p<0.001)。

证据类型、等级与局限

  • 证据类型:全国性、多中心、回顾性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为校园内自动体外除颤器的使用虽较其他公共场所更常见,但仍应改进。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

AIM: We sought to describe the characteristics of at-school out-of-hospital cardiac arrests cases, subsequent basic life support, as well as ultimate patient outcomes.

METHODS: This was a nation-wide, multicentre, retrospective cohort study from the French national population-based RéAC out-of-hospital cardiac arrest registry (July 2011 - March 2023). We compared the characteristics and outcomes of cases occurring at schools vs. in other public places.

RESULTS: Of the 149,088 national out-of-hospital cardiac arrests, 25,071 were public: 86 (0.3%) and 24,985 (99.7%) in schools and other public places, respectively. At-school out-of-hospital cardiac arrests, in comparison to other public places, were: significantly younger (median: 42.5 vs. 58 years, p < 0.001); more commonly of a medical cause (90.7% vs. 63.8%, p < 0.001), more commonly bystander-witnessed (93.0% vs. 73.4%, p < 0.001) and recipients of bystander cardiopulmonary resuscitation (78.8% vs. 60.6%, p = 0.001) with shorter median no-flow durations (2 min. vs. 7 min.); with greater bystander automated external defibrillator application (38.9% vs. 18.4%) and defibrillation (23.6%, vs. 7.9%; all p < 0.001). At-school patients had greater rates of return of spontaneous circulation than out-of-school ones (47.7%, vs. 31.8%; p = 0.002), higher rates of survival at arrival at hospital (60.5% vs. 30.7%; p < 0.001) and at 30-days (34.9% vs. 11.6%; p < 0.001), and survival with favourable neurological outcomes at 30 days (25.9% vs. 9.2%; p < 0.001).

CONCLUSION: At-school out-of-hospital cardiac arrests were rare in France, however demonstrated favourable prognostic features and outcomes. The use of automated external defibrillators in at-school cases, while more common than cases occurring elsewhere, should be improved.

来源:Resuscitation,查看原文。版权归原作者所有。

参考来源

  1. Lafrance M, Canon V, Hubert H, et al. Out-of-hospital cardiac arrests occurring at school in France: A nation-wide retrospective cohort study from the RéAC registry. Resuscitation. 2023. PMID: 37380064. doi:10.1016/j.resuscitation.2023.109888

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。